Question 1

What is the catalog number for FGFR4 (Fibroblast Growth Factor Receptor 4, CD334, JTK2, TKF)?

Accepted Answer

The catalog number for FGFR4 (Fibroblast Growth Factor Receptor 4, CD334, JTK2, TKF) is 363112.

Question 2

What sizes are available for FGFR4 (Fibroblast Growth Factor Receptor 4, CD334, JTK2, TKF)?

Accepted Answer

FGFR4 (Fibroblast Growth Factor Receptor 4, CD334, JTK2, TKF) is available in the following size(s): 200 µL.

Question 3

Is FGFR4 (Fibroblast Growth Factor Receptor 4, CD334, JTK2, TKF) in stock?

Accepted Answer

FGFR4 (Fibroblast Growth Factor Receptor 4, CD334, JTK2, TKF) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What host species was used to raise this antibody?

Accepted Answer

The host species used in production is listed under product specifications on the datasheet, and is relevant when selecting a compatible secondary antibody for your assay.

Question 5

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Question 6

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

FGFR4 (Fibroblast Growth Factor Receptor 4, CD334, JTK2, TKF)

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

6-Amino-5-nitrouracil-13C3

Cytoplasmic dynein 1 light intermediate chain 1 (DYNC1LI1) Human Gene Knockout Kit (CRISPR)

CD59 / Complement Regulatory Protein / Protectin (MACIF/2867R), CF640R conjugate, 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20), 0.2mg/mL

Tissue FFPE Sections, Testis

Phospho-RSK1 p90 (T359 + S363) Recombinant Rabbit Monoclonal Antibody [SU03-65]